FR2562421B1 - Perfectionnements a la therapie par l'interleukine - Google Patents

Perfectionnements a la therapie par l'interleukine

Info

Publication number
FR2562421B1
FR2562421B1 FR858505117A FR8505117A FR2562421B1 FR 2562421 B1 FR2562421 B1 FR 2562421B1 FR 858505117 A FR858505117 A FR 858505117A FR 8505117 A FR8505117 A FR 8505117A FR 2562421 B1 FR2562421 B1 FR 2562421B1
Authority
FR
France
Prior art keywords
interleukin therapy
interleukin
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR858505117A
Other languages
English (en)
Other versions
FR2562421A1 (fr
Inventor
Thomas Kissel
Jurg Reinhardt
Henriette Schrank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848409125A external-priority patent/GB8409125D0/en
Priority claimed from GB848409126A external-priority patent/GB8409126D0/en
Priority claimed from GB848409128A external-priority patent/GB8409128D0/en
Priority claimed from GB848409127A external-priority patent/GB8409127D0/en
Priority claimed from GB848420381A external-priority patent/GB8420381D0/en
Priority claimed from GB848423700A external-priority patent/GB8423700D0/en
Priority claimed from GB848423701A external-priority patent/GB8423701D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2562421A1 publication Critical patent/FR2562421A1/fr
Application granted granted Critical
Publication of FR2562421B1 publication Critical patent/FR2562421B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR858505117A 1984-04-09 1985-04-02 Perfectionnements a la therapie par l'interleukine Expired FR2562421B1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB848409125A GB8409125D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409126A GB8409126D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409128A GB8409128D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409127A GB8409127D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848420381A GB8420381D0 (en) 1984-08-10 1984-08-10 Interleukin therapy
GB848423700A GB8423700D0 (en) 1984-09-19 1984-09-19 Interleukin therapy
GB848423701A GB8423701D0 (en) 1984-09-19 1984-09-19 Interleukin therapy

Publications (2)

Publication Number Publication Date
FR2562421A1 FR2562421A1 (fr) 1985-10-11
FR2562421B1 true FR2562421B1 (fr) 1989-02-17

Family

ID=27562708

Family Applications (1)

Application Number Title Priority Date Filing Date
FR858505117A Expired FR2562421B1 (fr) 1984-04-09 1985-04-02 Perfectionnements a la therapie par l'interleukine

Country Status (13)

Country Link
US (1) US4863740A (fr)
JP (1) JPH0665650B2 (fr)
AU (1) AU4094685A (fr)
CH (1) CH668554A5 (fr)
DE (1) DE3512926A1 (fr)
DK (1) DK155085A (fr)
FR (1) FR2562421B1 (fr)
GB (1) GB2157172B (fr)
IL (1) IL74835A0 (fr)
IT (1) IT1199967B (fr)
LU (1) LU85839A1 (fr)
NL (1) NL8501010A (fr)
SE (1) SE8501709L (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
DE3682257D1 (de) * 1985-11-22 1991-12-05 Takeda Chemical Industries Ltd Liposomzusammensetzung.
EP0274219A3 (fr) * 1986-12-04 1988-08-03 Takeda Chemical Industries, Ltd. Composition de liposome contenant de l'interleukine-2 et méthode de sa fabrication
FR2624741B1 (fr) * 1987-12-21 1991-06-28 Pasteur Institut Compositions a base d'une combinaison de liposomes et de lymphokine presentant des proprietes immunostimulantes et leurs applications en medecine humaine et veterinaire
US5258499A (en) * 1988-05-16 1993-11-02 Vestar, Inc. Liposome targeting using receptor specific ligands
EP0577146A3 (fr) * 1988-05-16 1994-02-02 NeXstar Pharmaceuticals, Inc. Liposomes couplés sur des hormones
EP0366770B1 (fr) * 1988-05-16 1994-02-09 Vestar, Inc. Liposomes accouples a des hormones
EP0440742B1 (fr) * 1988-10-27 1997-01-15 The Regents Of The University Of Minnesota Immunoadjuvants liposomiques contenant de l'il-2
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
ATE136211T1 (de) * 1989-06-23 1996-04-15 Liposome Co Inc Zielliposomen und verfahren zur kupplung von liposomen-proteinen
JPH0363298A (ja) * 1989-07-31 1991-03-19 Green Cross Corp:The コロニー形成刺激因子・脂質複合体
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5268454A (en) 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5817333A (en) * 1991-10-31 1998-10-06 Fujisawa Pharmaceutical Co., Ltd. Liposome preparation containing a tricyclic compound
JPH07502734A (ja) * 1991-12-31 1995-03-23 ザイモジェネティクス，インコーポレイティド 血液損失を減少する方法および組成物
US5229109A (en) * 1992-04-14 1993-07-20 Board Of Regents, The University Of Texas System Low toxicity interleukin-2 analogues for use in immunotherapy
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
US5449663A (en) * 1993-06-11 1995-09-12 Bicher; Haim I. Antineoplastic compositions
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6033645A (en) * 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6406689B1 (en) 1995-10-03 2002-06-18 Frank W. Falkenberg Compositions and methods for treatment of tumors and metastatic diseases
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6339068B1 (en) 1997-05-20 2002-01-15 University Of Iowa Research Foundation Vectors and methods for immunization or therapeutic protocols
DE69829995T2 (de) * 1997-12-01 2006-02-23 Fang, Fang, San Diego Multivalente rekombinante antikörper zur behandlung von hrv infektionen
US20010003580A1 (en) * 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
AU756570B2 (en) * 1998-01-16 2003-01-16 Biomira Inc. Lipomatrix preparation
DK1105096T3 (da) 1998-08-19 2004-03-08 Skyepharma Canada Inc Injicerbare vandige propofoldispersioner
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
CA2403205A1 (fr) 2000-03-13 2001-09-20 Engene, Inc. Compositions et methodes destinees a l'expression regulee d'une proteine dans l'intestin
WO2001070763A1 (fr) * 2000-03-22 2001-09-27 The Children's Hospital Of Philadelphia Facteurs de coagulation sanguine modifies et leur procede d'utilisation
CA2898314A1 (fr) 2001-07-19 2003-07-31 Perian Therapeutics, Inc. Proteines multimeres et methodes de production et d'utilisation de ces proteines
US20030044354A1 (en) * 2001-08-16 2003-03-06 Carpenter Alan P. Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
TWI461436B (zh) 2005-11-25 2014-11-21 Kyowa Hakko Kirin Co Ltd 人類ｃｄ１３４（ｏｘ４０）之人類單株抗體及其製造及使用方法
EP1795540A1 (fr) 2005-11-30 2007-06-13 Imaxio Complexes multiples d'antigènes et d'un adjuvant
EP2015785A4 (fr) * 2006-04-24 2009-07-15 Shantha West Inc Antigène agrm2
EP2101813B1 (fr) 2006-11-27 2014-04-02 Patrys Limited Nouvelle cible de peptide glycosylé dans des cellules néoplasiques
EP2417984B1 (fr) 2009-04-10 2016-03-30 Kyowa Hakko Kirin Co., Ltd. Procédé pour le traitement d'une tumeur sanguine utilisant un anticorps anti-tim-3
CN104558179A (zh) 2009-04-27 2015-04-29 协和发酵麒麟株式会社 用于治疗血液肿瘤的抗IL-3Rα抗体
WO2011060233A1 (fr) 2009-11-11 2011-05-19 The Trustees Of The University Of Pennsylvania Anticorps anti-tem1 et leurs utilisations
WO2013162748A1 (fr) 2012-04-27 2013-10-31 The Trustees Of The University Of Pennsylvania Variants d'anticorps anti-marqueur 1 endothélial de tumeur (tem1) et leurs utilisations
US9790269B2 (en) 2013-02-08 2017-10-17 Misfolding Diagnostics, Inc. Transthyretin antibodies and uses thereof
US20160152952A1 (en) 2013-06-25 2016-06-02 Temple University-Of The Commonwealth System Of Higher Education Cortical Bone-Derived Stem Cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
GB1578776A (en) * 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
JPS56127308A (en) * 1980-03-11 1981-10-06 Green Cross Corp:The Blood-coagulation factor 8 pharmaceutical
EP0088046B1 (fr) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipides en phase aqueuse
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
AU564876B2 (en) * 1982-03-29 1987-08-27 Liposome Company, Inc., The Stable plurilamellar vesicles
AU573193B2 (en) * 1982-11-23 1988-06-02 Bio-Response Inc. Method for isolating cells
WO1985000606A1 (fr) * 1983-07-19 1985-02-14 Takeda Chemical Industries, Ltd. Il-2 humaine et son procede de preparation
US4464461A (en) * 1983-07-22 1984-08-07 Eastman Kodak Company Development of light-sensitive quinone diazide compositions
US4764359A (en) * 1984-05-25 1988-08-16 Lemelson Jerome H Drug compositions and their use in treating human or other mammalian patients
CA1260393A (fr) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes de lipides synthetiques

Also Published As

Publication number Publication date
IT8547939A1 (it) 1986-10-09
GB8508809D0 (en) 1985-05-09
SE8501709L (sv) 1985-10-10
DE3512926A1 (de) 1985-10-24
FR2562421A1 (fr) 1985-10-11
DK155085D0 (da) 1985-04-03
AU4094685A (en) 1985-10-17
IT8547939A0 (it) 1985-04-09
JPS60243022A (ja) 1985-12-03
US4863740A (en) 1989-09-05
GB2157172A (en) 1985-10-23
DK155085A (da) 1985-10-10
NL8501010A (nl) 1985-11-01
GB2157172B (en) 1988-12-29
CH668554A5 (de) 1989-01-13
JPH0665650B2 (ja) 1994-08-24
LU85839A1 (fr) 1985-12-16
IL74835A0 (en) 1985-07-31
SE8501709D0 (sv) 1985-04-04
IT1199967B (it) 1989-01-05

Similar Documents

Publication Publication Date Title
FR2562421B1 (fr) Perfectionnements a la therapie par l'interleukine
IT1188608B (it) Unita' a tettarella
IT8620090A1 (it) Nuovo coniugato nucleoside-fosfolipide
FR2590194B1 (fr) Mecanisme d'agrafeuse
DE3464322D1 (en) Patient's support
DE3566220D1 (en) Patient's support
FR2580495B1 (fr) Preparation dentaire a base d'emulsanne
FR2565312B1 (fr) Mecanisme d'entrainement de cadenceur
IT1200449B (it) Intensificatore d'immagine a medi-infrarossi
SG45992G (en) A slice amplifier using fet's
PH22526A (en) 2-2' bi-ih-imidazoles
IT1189547B (it) Unita' di impostazione elettroidraulica
SU1268026A1 (ru) Мощный импульсный тиристор
KR860000031U (ko) 탕비기의 푸시버튼식 조작장치
LV5402A3 (lv) Kardioprotektors "Mildonats"
FR2558615B1 (fr) Controleur integre d'unite a disque souple
BR8507317A (pt) Gurinchuk 11)v a
KR860007548U (ko) 프레스의 파이롯드 고정장치
MA20618A1 (fr) Variete clementinier precoce "ripetri"
IT8403550A0 (it) Compressore-generatore a contemporaneita' d'impiego
LV5111A3 (lv) Buvmateriala izgatavosanas panemiens
IT8533604V0 (it) "utility - belt"
IT8533609V0 (it) "utility-notes"
IT8533602V0 (it) "polifemo"
IT8511793V0 (it) "stendiarredo"

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse